HC Wainwright & Co. reiterated coverage on Redhill Biopharma with a new price target

9/15/21 6:06:43 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. reiterated coverage of Redhill Biopharma with a rating of Buy and set a new price target of $21.00 from $23.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$RDHL

Date	Price Target	Rating	Analyst
9/15/2021	$23.00 → $21.00	Buy	HC Wainwright & Co.
8/31/2021	$22.00	Overweight	Cantor Fitzgerald